Mobilization of Viable Tumor Cells Into the Circulation During Radiation Therapy
- 1 February 2014
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 88 (2), 395-403
- https://doi.org/10.1016/j.ijrobp.2013.10.033
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Circulating Tumor Cells in Lung CancerActa Cytologica, 2012
- Establishment of animal model for the analysis of cancer cell metastasis during radiotherapyRadiation Oncology, 2012
- Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biologyPhysical Biology, 2012
- Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapyFrontiers in Oncology, 2012
- γH2AX foci as a measure of DNA damage: A computational approach to automatic analysisMutation Research, 2011
- Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor CellsClinical Cancer Research, 2010
- γ-H2AX as a biomarker of DNA damage induced by ionizing radiation in human peripheral blood lymphocytes and artificial skinAdvances in Space Research, 2009
- γH2AX and cancerNature Reviews Cancer, 2008
- Microenvironmental regulation of metastasisNature Reviews Cancer, 2008
- Metabolic (FDG–PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failureLung Cancer, 2005